Concepedia

Author

Peter Brossart

University of TübingenORCID

Also Known As

Brossart Peter, Brossart, Peter, D Weber, Heinz-A. Horst, J. Krauter, M Schenk, P Brossart, P. BROSSART, P. Brossart, P., Brossart

547

Publications

19.7K

Citations

75

H-Index

134

Concepts

All Affiliations

University of TübingenUniversity Hospital BonnUniversity of BonnHeidelberg UniversityCharité - Universitätsmedizin Berlin
PB

About

Peter Brossart is an author at University of Tübingen specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

39

75

5.3K

2

Health Sciences

9

9

684

3

Engineering

1

1

24

4

Natural Sciences

1

1

65

5

Public Health

1

1

37

Peter Brossart

×

197

Publications

15.7K

Citations

70

H-Index

YearCitations

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids

A. Kugler, Gernot Stuhler, Peter Walden,

Nature Medicine

2000

645

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells

Peter Brossart, Stefan Wirths, Gernot Stuhler,

Blood

2000

539

Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation

Richard F. Schlenk, Sabine Käyser, Lars Bullinger,

Blood

2014

394

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi,

Journal of Clinical Oncology

2016

375

The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo

Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke,

Blood

2013

338

Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies

Peter Brossart, Kathrin Heinrich, Gernot Stuhler,

Blood

1999

296

Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses

M. Hipp, Norbert Hilf, Steffen Walter,

Blood

2008

283

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells

Susanne M. Schmidt, Kerstin Schag, Martin Müller,

Blood

2003

277

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil,

Leukemia

2016

264

Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL.

Peter Brossart, Ananda W. Goldrath, Eric Butz,

PubMed

1997

251

Page 1